Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace

Recruiting Observational Study
Human Anaplasmosis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
University Hospital, Strasbourg, France · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Anaplasmosis is a bacterial infection caused by the intracellular bacterium Anaplasma phagocytophilum and transmitted by ticks. This bacterium is present in approximately 1% of ticks in Alsace. This infection is responsible for clinical manifestations that are most often mild, including fever, headache, and myalgia, occurring 2 to 3 weeks after a tick bite. However, this infection can be accompani…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult subjct (≥18 years) * Presenting with a PCR-confirmed infection of Anaplasma Exclusion Criteria: \- Refusal to participate in the study
Contacts

Victor GERBER, MD

33 3.88.11.67.68

victor.gerber@chru-strasbourg.fr

CONTACT